Centrient Pharmaceuticals India Private Limited
FDA inspection history on file, 2022 to 2026
- 1
- Form 483
- 1
- Warning letter
Every document, by year
- Form 483
- Warning letter
2022: one warning letter; 2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2022One warning letter.
- 2026One Form 483.
The complete Centrient Pharmaceuticals India Private Limited file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-01-19 | 483 Form 483 | — | 3 | $99 |
| 2022-12-07 | Warning letter Warning letter | — | — | $99 |
FEI number 3004497364 · most recent document Jan 19, 2026
About Centrient Pharmaceuticals India Private Limited
How many FDA Form 483s has Centrient Pharmaceuticals India Private Limited received?
FDA Intel has 1 Form 483 on file for Centrient Pharmaceuticals India Private Limited; the most recent is dated Jan 19, 2026.
When was Centrient Pharmaceuticals India Private Limited last inspected by FDA?
The most recent FDA inspection document on file for Centrient Pharmaceuticals India Private Limited is a Form 483 dated Jan 19, 2026.
Has Centrient Pharmaceuticals India Private Limited received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Centrient Pharmaceuticals India Private Limited; the most recent is dated Dec 7, 2022.